Navigation Links
Mpex Candidate, MP-376, Granted U.S. Orphan Drug Status for the Treatment of Cystic Fibrosis
Date:3/4/2008

's marketing approval by the FDA. Orphan status also enables Mpex to apply for research funding, tax credits for certain research expenses, and a waiver from FDA user fees.

About MP-376

MP-376 is a proprietary formulation of levofloxacin that has been designed by Mpex scientists to enable aerosol administration. Levofloxacin is a powerful antibiotic that has been widely used in a variety of indications for over a decade and has established safety and efficacy when administered orally or intravenously against many bacterial pathogens including Pseudomonas aeruginosa. Administration of MP-376 with a high efficiency nebulizer to the lungs allows for the delivery of high concentrations of active drug directly to the site of infection, while minimizing systemic exposure. Mpex believes this approach has the potential to improve bacterial killing and reduce resistance development versus traditional oral or IV routes of administration.

Mpex recently completed a multi-center, 14-day placebo controlled clinical trial with MP-376 in 40 CF patients. Based on these results and consultations with the FDA and the Therapeutics Development Network (TDN) of the Cystic Fibrosis Foundation, the company expects to initiate a Phase 2b clinical trial in approximately 140 CF patients in the second quarter of 2008. Several dosing regimens of MP-376 will be compared, including once daily administration schedules. Results from this trial, if successful, are expected to enable the company to select dosing regimens for the pivotal Phase 3 clinical program in this indication.

About Mpex Pharmaceuticals

Mpex Pharmaceuticals is a clinical stage biopharmaceutical company whose mission is to develop important new therapies to combat the growing issue of antibiotic resistance. The company's internal development pipeline focuses on combining proprietary formulations, PK/PD strategies and novel potentiating agents with proven antibiotics to overcome or directly inhibi
'/>"/>

SOURCE Mpex Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related biology technology :

1. Odyssey Thera Granted U.S. Patent for Animal Imaging
2. ISTO Technologies Granted Key Patent for Cartilage Cell Expansion by the United States Patent Office
3. Pharmion and MethylGene Announce Orphan Drug Designation Granted by the European Medicines Agency (EMEA) for MGCD0103 for the Treatment of Hodgkins Lymphoma
4. PREOS(R) Granted U.S. Orphan Drug Status for Treatment of Hypoparathyroidism
5. Pharmions Oral Azacitidine Granted Fast Track Status for Myelodysplastic Syndromes
6. ADVENTRX Announces Fast Track Designation Granted By the FDA For CoFactor For the Treatment of Metastatic Colorectal Cancer
7. Raptor Pharmaceuticals Acquires Orphan Clinical Program
8. Sequella Lead Drug Compound SQ109 Receives Orphan Drug Status From the US FDA and Orphan Medicinal Product Designation From the European Medicines Agency for the Treatment of Tuberculosis
9. Poniard Pharmaceuticals Announces European Commission Grants Orphan Medicinal Product Designation to Picoplatin for Treatment of Small Cell Lung Cancer
10. FDA Grants Orphan Drug Designation to TREANDA, an Investigational Treatment for Chronic Lymphocytic Leukemia
11. AGA Medical Corporation Responds to Occlutech Statement on the Status of the Ongoing Patent Litigation in Europe
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/21/2008)...INE, Calif., Nov. 21 Cor... plans to provide "agent" services under the new,...for insurers, third party,administrators and empl...et-Aside (MSA) services for workers, compensation ...untry, and is expanding that service offering to,...
(Date:11/21/2008)... DuPont Knowledge Center is ...ed States. , Hyderabad, I...ned the DuPont Knowledge Center (DKC) today, 17 mo...n 15 acres in the ICICI Knowledge Park in the city...rch hub for India and the Asia Pacific region in t...
(Date:11/21/2008)...LUATION OF VARIOUS FINANCIAL AND RESTRUCTURING ALT...RNewswire-FirstCall/ - Angiotech Pharmaceuticals, ...ty pharmaceutical and medical device company, toda...Ares Management (Ares) and New Leaf Venture Partne...he Note Purchase Agreement dated July 7, 2008. Ang...
(Date:11/21/2008)...CINNATI, Nov. 21 LCA-Vis... laser vision correction services under the,Lasik...Michael J. Celebrezze,to the position of Chief Fi...ecember 1, 2008. Mr. Celebrezze, who has served a...he LCA-Vision Executive Management team as Senior ...
Breaking Biology Technology:CorVel Announces MSA Agent Services 2CorVel Announces MSA Agent Services 3DuPont Opens Research & Development Center in India 2DuPont Opens Research & Development Center in India 3Angiotech announces termination of note purchase agreement with Ares Management and New Leaf Venture Partners 2Angiotech announces termination of note purchase agreement with Ares Management and New Leaf Venture Partners 3Angiotech announces termination of note purchase agreement with Ares Management and New Leaf Venture Partners 4LCA-Vision Names Michael J. Celebrezze CFO 2LCA-Vision Names Michael J. Celebrezze CFO 3LCA-Vision Names Michael J. Celebrezze CFO 4
...,s ability to build a community of life science to...technology company chose to relocate here as part ...Baird Venture Partners . , ,The company, Caden Bi... New Venture Center on the Fitchburg Technology C... of Northwestern University , has developed a yet...
...usinesses interested in tapping into $2 billion in...able to learn what it takes to win these competiti...ee. , ,Firms in the entrepreneurial sector are enc...R Conference from Nov. 6 to 9 at the Hilton Milw... information and workshops on federal programs tha...
...ng filed its postponed annual and quarterly earnin...st its common stock on The N asdaq Stock Market ...rom NASDAQ staff on Friday, stating that the stock...ned to continue the listing of the stock. , ,Merge...tware provider, has been working to catch up with ...
...eparting for Osaka, Japan, for the Bio Japan 2006...I have written a number of times over the years ab...s, but I haven,t been back to Japan for a few year...n the development of the biotech industry there. ,...ties and my last visit was part of the festivities...
Other Biology Technology:Biotech talent drew venture-funded firm to Madison 2Biotech talent drew venture-funded firm to Madison 3Chinese pharma-biotech dragon rears its head 2Chinese pharma-biotech dragon rears its head 3Chinese pharma-biotech dragon rears its head 4Chinese pharma-biotech dragon rears its head 5Chinese pharma-biotech dragon rears its head 6
(Date:11/20/2008)... , WASHINGTON, DC Although Americans are becomin...om everyday household products like bisphenol A in... not readily connect typical household products wi...health effects, according to research from the Dec...ehavior . , "People more readily equate polluti...
(Date:11/20/2008)... , Neuroscientists at Barrow Neurological Insti...ave discovered a direct link between eye motions a... 200-year-old debate. , Stephen Macknik, PhD, ...iology; Susana Martinez-Conde, PhD, director of th...coso, PhD; and Jorge Otero-Millan; conducted a stu...
(Date:11/20/2008)... , For millennia, people have grown soybeans and ... comes to understanding why a soybean grows, bloom...ith unanswered questions. , University of Georg...s with a three-year, $2.5 million grant from the N...ice found by a UGA colleague. , "I,m convinced t...
(Date:11/19/2008)... , , The health threat to city dwellers posed by ...er 2008 may have been underestimated by officials....oduced by previous California wild fires indicates... threats to health than is generally realized, acc... (PM) from wildfires in Southern California. , T...
Breaking Biology News(10 mins):Pollution at home lurks unrecognized, instead attributed to large-scale environmental disasters 2Soybean grant gives researchers tools to unravel better bean 2Where there's wildfire smoke, there's toxicity 2CV Therapeutics Anti Ischemic Agent Ranexa 28R 29 Significantly Reduces HbA1c and Other Markers of Diabetes in MERLIN TIMI 36 772 1CV Therapeutics Anti Ischemic Agent Ranexa 28R 29 Significantly Reduces HbA1c and Other Markers of Diabetes in MERLIN TIMI 36 772 2CV Therapeutics Anti Ischemic Agent Ranexa 28R 29 Significantly Reduces HbA1c and Other Markers of Diabetes in MERLIN TIMI 36 772 3CV Therapeutics Anti Ischemic Agent Ranexa 28R 29 Significantly Reduces HbA1c and Other Markers of Diabetes in MERLIN TIMI 36 772 4Frontiers in Cancer Prevention Research 1128 1MicroActive Corporation Acquired by Linden and Edgewater 5649 1MicroActive Corporation Acquired by Linden and Edgewater 5649 2New Study Reveals MRSA Bacteria Common Among Pigs and Farm Workers 5647 1New Study Reveals MRSA Bacteria Common Among Pigs and Farm Workers 5647 2New Study Reveals MRSA Bacteria Common Among Pigs and Farm Workers 5647 3
... An estimated ten million Americans suffer from os...t risk of developing the disease, which is charact...ragile bones and an increased risk of hip, spine a...eoporosis involves an imbalance between bone miner... processes that lead to this imbalance are not com...
... Body mass index, or BMI, long considered the stan... body, may not be as accurate as originally though...om Michigan State University and Saginaw Valley St...ollege students ?some of whom were athletes and so... BMI did not accurately reflect his or her percent...
... UC Irvine researchers have combined genetic and g...nstruct its history over the past decade. They fou...n the Chinese province of Guangdong, and they iden...the strains spread regionally and internationally....te, health officials can better limit the spread o...
... Rabies, a relentless, ancient scourge, may hold a...entists at Jefferson Medical College in Philadelph...o ferry HIV-related proteins into animals, in esse.... The early evidence shows that the vaccine ?which...opment of disease. , Reporting April 1, 2007 in t...
Other Biology News:BMI not accurate indicator of body fat 2UCI scientists reconstruct migration of avian flu virus 2Jefferson scientists find rabies-based vaccine could be effective against HIV 2
Clear yellow solution. In PBS containing BSA, 0.01% thimerosal, and other proprietary stabilizers; 0.2 M filtered. Diluent formulated to stabilize activity of horseradish peroxidase antibody conjugat
The Gene Pulser Xcell eukaryotic system, 100 to 240 V, 50-60 Hz, is used for electroporation of mammalian cells. This system includes the main unit, CE module for exponential (25-3,275 microfarad ran
MacMelt software is used on Macintosh operating systems to predict the melting profile of any DNA sequence up to 3,200 bases, which aids in optimizing placement of primers and GC clamps for mutation
...ons RNAi Services offer you a full range of soluti...ign parameters, effective synthetic siRNA reagents...uality results from your siRNA experiments. siSolu...ary B-Algo algorithm to define siRNA sequences wit...
Biology Products: